Legend Biotech Corporation
LEGN
$18.55
-$0.55-2.88%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 306.49M | 272.31M | 255.06M | 194.96M | 192.61M |
| Total Other Revenue | -111.00K | 18.00K | 3.00K | 90.00K | -6.03M |
| Total Revenue | 306.38M | 272.33M | 255.06M | 195.05M | 186.58M |
| Cost of Revenue | 224.79M | 228.45M | 196.29M | 173.27M | 178.33M |
| Gross Profit | 81.59M | 43.88M | 58.77M | 21.79M | 8.25M |
| SG&A Expenses | 101.19M | 87.33M | 80.65M | 72.43M | 83.16M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 1.00M | -- | -- | -- | -- |
| Total Operating Expenses | 326.98M | 315.78M | 276.94M | 245.70M | 261.49M |
| Operating Income | -20.60M | -43.45M | -21.88M | -50.65M | -74.91M |
| Income Before Tax | -19.60M | -39.07M | -124.80M | -99.13M | 40.54M |
| Income Tax Expenses | 11.22M | 616.00K | 582.00K | 1.79M | 14.23M |
| Earnings from Continuing Operations | -30.82M | -39.69M | -125.38M | -100.92M | 26.31M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -30.82M | -39.69M | -125.38M | -100.92M | 26.31M |
| EBIT | -20.60M | -43.45M | -21.88M | -50.65M | -74.91M |
| EBITDA | -17.92M | -41.53M | -19.50M | -48.24M | -72.17M |
| EPS Basic | -0.33 | -0.43 | -1.36 | -1.10 | 0.29 |
| Normalized Basic EPS | -0.07 | -0.13 | -0.42 | -0.33 | 0.15 |
| EPS Diluted | -0.36 | -0.44 | -1.36 | -1.10 | 0.29 |
| Normalized Diluted EPS | -0.07 | -0.13 | -0.42 | -0.33 | 0.14 |
| Average Basic Shares Outstanding | 184.73M | 184.64M | 184.14M | 183.76M | 183.32M |
| Average Diluted Shares Outstanding | 92.37M | 92.32M | 92.07M | 91.88M | 100.70M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |